MiniMed Group, Inc.

MiniMed Group, Inc.

18.65
USD
+0.66
(+3.67%)
-1.16EPS
5.08BMarket Cap
Dec 30Next Earn

Total Valuation

USD

As of July 31, 2026, MiniMed Group, Inc. carries a market capitalization of 5.08B, placing it among publicly traded companies globally. Its enterprise value stands at 4.88B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap5.08B
Enterprise Value4.88B

Important Dates

MiniMed Group, Inc.'s next confirmed earnings release is scheduled for December 30, 2026.

Earnings Date12/30/2026

Share Statistics

As of July 31, 2026, MiniMed Group, Inc. has 281.21M shares outstanding.

Shares Outstanding281.21M

Valuation Ratios

These figures are as of July 31, 2026. The price-to-sales ratio is 1.57, and the price-to-book ratio stands at 1.40.

PS Ratio1.57
PB Ratio1.40
P/TBV Ratio4.01
P/FCF Ratio-16.04
P/OCF Ratio-48.28

Enterprise Valuation

These figures are as of July 31, 2026. The EV/Sales ratio of 1.51 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 4.88B versus a market cap of 5.08B, with the gap driven by net debt and cash on the balance sheet.

EV / Sales1.51

Financial Position

As of July 31, 2026, MiniMed Group, Inc. maintains a current ratio of 1.81, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities.

Current Ratio1.81
Quick Ratio1.26
Debt / Equity0.25
Debt / EBITDA-0.22

Financial Efficiency

USD

These figures cover the twelve months ended July 31, 2026. The company generates approximately 402,750.00 in revenue per employee across its workforce of 8,000.00, a quick read on workforce productivity versus industry peers.

Revenue Per Employee402,750.00
Employee Count8,000.00

Taxes

USD

Over the twelve months ended July 31, 2026, MiniMed Group, Inc. recorded 128.00M in income tax expense. The company reported a pretax loss of -199.00M and -331.00M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Income Tax128.00M

Stock Price Statistics

USD

These figures are as of the close on November 16, 2026.

50-Day Moving Average19.51

Income Statement

USD

Over the twelve months ended July 31, 2026, MiniMed Group, Inc. generated 3.22B in revenue and converted that into -331.00M in net income, yielding earnings per share of -1.16. EBITDA reached -41.00M, while operating income came in at -188.00M.

Revenue3.22B
Gross Profit1.74B
Operating Income-188.00M
Pretax Income-199.00M
Net Income-331.00M
EBITDA-41.00M
EBIT-199.00M
Earnings Per Share (EPS)-1.16

Balance Sheet

USD

As of July 31, 2026, MiniMed Group, Inc. holds 207.00M in cash and equivalents against 9.00M in total debt, resulting in a net debt position of -207.00M. Total book value stands at 3.62B, with working capital of 635.00M providing operational flexibility.

Cash & Cash Equivalents207.00M
Total Debt9.00M
Net Debt-207.00M
Equity (Book Value)3.62B
Book Value Per Share12.87
Working Capital635.00M

Cash Flow

USD

MiniMed Group, Inc. produced -105.00M in operating cash flow over the twelve months ended July 31, 2026. After subtracting -211.00M in capital expenditures, free cash flow totaled -316.00M - equivalent to -1.13 per share.

Operating Cash Flow-105.00M
Capital Expenditures-211.00M
Free Cash Flow-316.00M
FCF Per Share-1.13

Margins

Over the twelve months ended July 31, 2026, MiniMed Group, Inc. posted a gross margin of 53.85, reflecting its pricing power and cost economics. The operating margin of -5.83 and net profit margin of -10.27 provide insight into operational efficiency.

Gross Margin53.85
Operating Margin-5.83
Pretax Margin-6.18
Profit Margin-10.27
EBITDA Margin-1.27

Dividends & Yields

These figures cover the twelve months ended July 31, 2026. Free cash flow yield is negative at -6.23: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -10.13, meaning MiniMed Group, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Shareholder Yield-10.13
FCF Yield-6.23

Scores

As of July 31, 2026, MiniMed Group, Inc. has an Altman Z-Score of 4.13, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score4.13